Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,074 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Durvalumab in combination with chemoradiotherapy for patients with unresectable stage III non-small-cell lung cancer: Results from the phase 1 CLOVER study.
Kim DW, Chul Cho B, Pachipala K, Kim SW, Wang CL, Chang GC, Ahn MJ, Alvarez R, Chiu CH, Trigo J, Estival A, Karam SD, O'Brien C, Gowda H, Jiang H, Bauman JE. Kim DW, et al. Among authors: alvarez r. Lung Cancer. 2024 Apr;190:107530. doi: 10.1016/j.lungcan.2024.107530. Epub 2024 Mar 7. Lung Cancer. 2024. PMID: 38471416 Free article. Clinical Trial.
Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatment in patients with stage III non-small cell lung cancer: A randomized phase II (RENO study).
Isla D, De Las Peñas R, Insa A, Marsé R, Martínez-Banaclocha N, Mut P, Morán T, Sala MÁ, Massuti B, Ortega AL, Jurado JM, Gómez-Codina J, Diz P, Artal Á, Gutiérrez V, Vázquez MF, Viñolas N, Maestu I, Camps C, Álvarez R, de Mon Soto MÁ, Ponce S, Provencio M. Isla D, et al. Among authors: alvarez r. Lung Cancer. 2019 Sep;135:161-168. doi: 10.1016/j.lungcan.2018.11.041. Epub 2018 Dec 1. Lung Cancer. 2019. PMID: 31446990 Clinical Trial.
Lung cancer patients with COVID-19 in Spain: GRAVID study.
Provencio M, Mazarico Gallego JM, Calles A, Antoñanzas M, Pangua C, Mielgo Rubio X, Nadal E, Castro RL, López-Martín A, Del Barco E, Dómine M, Franco F, Diz P, Sandoval C, Girona ES, Sullivan I, Sala MÁ, Ledo GG, Cucurull M, Mosquera J, Martínez M, Chara LE, Arriola E, Herrera BE, Jarabo JR, Álvarez RÁ, Baena J, Cao MG. Provencio M, et al. Lung Cancer. 2021 Jul;157:109-115. doi: 10.1016/j.lungcan.2021.05.014. Epub 2021 May 14. Lung Cancer. 2021. PMID: 34016490 Free PMC article.
ASTRIS, a large real-world study to evaluate the efficacy of osimertinib in epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer patients: Clinical characteristics and genotyping methods in a Spanish cohort.
Vicente-Baz D, Paredes A, Morán T, Massuti B, Reguart N, Álvarez R, Insa A, Juan-Vidal O, Artal Á, Esteban E, García-Campelo R, Ortega-Granados AL, Diz P, González-Larriba JL, Terrasa J, de Las Peñas R, Rodríguez-Abreu D, Callejo Á, Márquez G, Provencio M. Vicente-Baz D, et al. Among authors: alvarez r. Rev Esp Patol. 2020 Jul-Sep;53(3):140-148. doi: 10.1016/j.patol.2019.11.002. Epub 2020 Jan 13. Rev Esp Patol. 2020. PMID: 32650965
Possible heart failure caused by osimertinib in a lung cancer patient.
Ruiz-Briones P, Escudero-Vilaplana V, Collado-Borrell R, Vicente-Valor J, Alvarez R, Villanueva-Bueno C, Narrillos-Moraza Á, Herranz A, Sanjurjo M. Ruiz-Briones P, et al. Among authors: alvarez r. J Oncol Pharm Pract. 2023 Jun;29(4):1015-1020. doi: 10.1177/10781552221143787. Epub 2022 Dec 8. J Oncol Pharm Pract. 2023. PMID: 36480925
Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non-small cell lung cancer in Spain.
Majem M, Álvarez R, Ortega AL, Ruiz de Alda L, Gordo R, García JF, Ivanova-Markova Y, González-Domínguez A, San Cristóbal RS, Rojo F. Majem M, et al. Among authors: alvarez r. Glob Reg Health Technol Assess. 2022 Sep 12;9:82-90. doi: 10.33393/grhta.2022.2449. eCollection 2022 Jan-Dec. Glob Reg Health Technol Assess. 2022. PMID: 36628311 Free PMC article.
Brief Report: Clinical Outcomes Using Plasma-Based Molecular Profiling to Guide Treatment Decisions in Patients With Advanced NSCLC and Limited Access to Broad Tissue Testing.
García-Pardo M, Aparicio I, Martínez Í, Arregui M, Tirado V, Galera M, Álvarez R, Calles A. García-Pardo M, et al. Among authors: alvarez r. Clin Lung Cancer. 2023 Jun;24(4):366-370. doi: 10.1016/j.cllc.2023.02.003. Epub 2023 Feb 9. Clin Lung Cancer. 2023. PMID: 36842853 No abstract available.
Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid.
Calles A, Aparicio MI, Alva M, Bringas M, Gutierrez N, Soto J, Arregui M, Tirado VC, Álvarez EL, Del Monte-Millán M, Massarrah T, Galera M, Álvarez R, Martín M. Calles A, et al. Among authors: alvarez r, alvarez el. Front Oncol. 2020 Sep 16;10:1777. doi: 10.3389/fonc.2020.01777. eCollection 2020. Front Oncol. 2020. PMID: 33042826 Free PMC article.
Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer.
Moreno-Rubio J, Ponce S, Álvarez R, Olmedo ME, Falagan S, Mielgo X, Navarro F, Cruz P, Cabezón-Gutiérrez L, Aguado C, Colmenarejo G, Muñoz-Fernández de Leglaria M, Enguita AB, Cebollero M, Benito A, Alemany I, Del Castillo C, Ramos R, Ramírez de Molina A, Casado E, Sereno M. Moreno-Rubio J, et al. Among authors: alvarez r. Cancer Biol Med. 2020 May 15;17(2):444-457. doi: 10.20892/j.issn.2095-3941.2019.0363. Cancer Biol Med. 2020. PMID: 32587780 Free PMC article.
2,074 results